These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32173274)

  • 21. Indiana community pharmacist preceptors' knowledge and perceptions of medication-assisted treatment.
    Davenport ES; Arnett SJ; Nichols MA; Miller ML
    J Am Pharm Assoc (2003); 2020; 60(3S):S20-S28.e4. PubMed ID: 32094038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Access to MAT: Participants' Experiences With Transportation, Non-Emergency Transportation, and Telehealth.
    Boyd J; Carter M; Baus A
    J Prim Care Community Health; 2024; 15():21501319241233198. PubMed ID: 38420885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing medication assisted treatment in rural primary care practice: a qualitative comparative analysis from IT MATTTRs Colorado.
    Holtrop JS; Mullen R; Curcija K; Rubinson C; Westfall JM; Nease DE; Zittleman L
    Front Med (Lausanne); 2024; 11():1450672. PubMed ID: 39416870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eight-hour medication-assisted treatment waiver training for opioid use disorder: integration into medical school curriculum.
    Lien IC; Seaton R; Szpytman A; Chou J; Webber V; Waineo E; Levine D
    Med Educ Online; 2021 Dec; 26(1):1847755. PubMed ID: 33222656
    [No Abstract]   [Full Text] [Related]  

  • 25. Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study.
    Finlay AK; Morse E; Stimmel M; Taylor E; Timko C; Harris AHS; Smelson D; Yu M; Blue-Howells J; Binswanger IA
    J Gen Intern Med; 2020 Sep; 35(9):2529-2536. PubMed ID: 32583337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "I didn't want to be on Suboxone at first…" - Ambivalence in Perinatal Substance Use Treatment.
    Ostrach B; Leiner C
    J Addict Med; 2019; 13(4):264-271. PubMed ID: 30585875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update.
    Andrilla CHA; Moore TE; Patterson DG; Larson EH
    J Rural Health; 2019 Jan; 35(1):108-112. PubMed ID: 29923637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between Medication Assisted Therapy Services Delivery and Mortality in a National Cohort of Veterans with Posttraumatic Stress Disorder and Opioid Use Disorder.
    Riblet NB; Gottlieb DJ; Shiner B; Cornelius SL; Watts BV
    J Dual Diagn; 2020; 16(2):228-238. PubMed ID: 31852392
    [No Abstract]   [Full Text] [Related]  

  • 29. Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder.
    van Reekum EA; Rosic T; Hudson J; Sanger N; Marsh DC; Worster A; Thabane L; Samaan Z
    Biol Sex Differ; 2020 Apr; 11(1):20. PubMed ID: 32326982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A qualitative process evaluation of a diabetes navigation program embedded in an endocrine specialty center in rural Appalachian Ohio.
    Beverly EA; Hamel-Lambert J; Jensen LL; Meeks S; Rubin A
    BMC Endocr Disord; 2018 Jul; 18(1):50. PubMed ID: 30053846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cultural perceptions of healthy weight in rural Appalachian youth.
    Williams KJ; Taylor CA; Wolf KN; Lawson RF; Crespo R
    Rural Remote Health; 2008; 8(2):932. PubMed ID: 18503293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the impact of an opioid-specific education series on rates of medication-assisted treatment for opioid use disorder in veterans.
    Kirby T; Connell R; Linneman T
    Am J Health Syst Pharm; 2021 Feb; 78(4):301-309. PubMed ID: 33289022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supportive environments during the substance use disorder epidemic in the rural United States: Provider support for interventions and expectations of interactions with providers.
    O'Brien TC; ; Feinberg J; Gross R; Albarracín D
    Soc Sci Med; 2022 Feb; 294():114691. PubMed ID: 35033798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review.
    Maglione MA; Raaen L; Chen C; Azhar G; Shahidinia N; Shen M; Maksabedian E; Shanman RM; Newberry S; Hempel S
    J Subst Abuse Treat; 2018 Jun; 89():28-51. PubMed ID: 29706172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's Disease and Related Disorders Prevalence Differs by Appalachian Residence in Ohio.
    Wing JJ; Levine DA; Ramamurthy A; Reider C
    J Alzheimers Dis; 2020; 76(4):1309-1316. PubMed ID: 32597814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Building Capacity for Medication Assisted Treatment in Rural Primary Care Practices: The IT MATTTRs Practice Team Training.
    Zittleman L; Curcija K; Sutter C; Dickinson LM; Thomas J; de la Cerda D; Nease DE; Westfall JM
    J Prim Care Community Health; 2020; 11():2150132720953723. PubMed ID: 32909491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of Prescription-Opioid-Impaired and Other Substance-Impaired Drivers in Rural Appalachian Kentucky.
    Webster JM; Dickson MF; Mannan F; Staton M
    J Psychoactive Drugs; 2018; 50(5):373-381. PubMed ID: 30204565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers and attitudes.
    Matusow H; Dickman SL; Rich JD; Fong C; Dumont DM; Hardin C; Marlowe D; Rosenblum A
    J Subst Abuse Treat; 2013; 44(5):473-80. PubMed ID: 23217610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "If You Could Wave a Magic Wand": Treatment Barriers in the Rural Midwest.
    Clark A; Lanzillotta-Rangeley J; Stem J
    Subst Abuse; 2021; 15():11782218211053343. PubMed ID: 34924756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. People, places, and stigma: A qualitative study exploring the overdose risk environment in rural Kentucky.
    Fadanelli M; Cloud DH; Ibragimov U; Ballard AM; Prood N; Young AM; Cooper HLF
    Int J Drug Policy; 2020 Nov; 85():102588. PubMed ID: 31753603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.